In Stock
Tirzepatide
10mg
Dual Incretin Receptor Engagement
Tirzepatide is a focus for researchers studying incretin biology. As a dual agonist, it engages both the GIP and GLP-1 receptors, providing a model for examining how combined incretin signaling differs from selective GLP-1 activation. Studies use Tirzepatide to investigate receptor-binding dynamics and the synergistic effects of dual engagement on pancreatic and metabolic signaling in cellular models.
Glucose Homeostasis & Insulin Response
In metabolic research, Tirzepatide is investigated for its influence on glucose-dependent insulin secretion. Researchers study how dual incretin signaling modulates the insulinotropic response in pancreatic beta-cell models, examining the interplay between the two receptor pathways in regulating glucose handling.
Adipose Metabolism & Energy Partitioning
Recent studies have utilized Tirzepatide to investigate effects on lipid metabolism. By examining how combined GIP and GLP-1 engagement influences adipose signaling and substrate partitioning, researchers explore the peptide's role in energy-balance and body-composition research within preclinical models.
For research use only.
Tirzepatide is a synthetic peptide widely studied for its dual-agonist activity, simultaneously targeting the GIP and GLP-1 receptors to investigate incretin-mediated metabolic signaling.
Yes. Tirzepatide is a synthetic peptide commonly investigated in preclinical research involving incretin biology, metabolic regulation, and endocrine signaling.
Tirzepatide is commonly investigated in studies involving GIP and GLP-1 receptor signaling, glucose homeostasis, insulin secretion, adipose metabolism, energy balance, body composition, and metabolic regulation.
Tirzepatide should be stored in a cool, dry environment. For long-term stability, lyophilized vials are typically kept frozen and protected from heat, moisture, and direct sunlight.
Tirzepatide is unique for its simultaneous activation of the GIP and GLP-1 receptors, making it a valuable research peptide for studying dual incretin signaling, metabolic regulation, glucose homeostasis, and energy balance.
Overview
Dual Incretin Receptor Engagement
Tirzepatide is a focus for researchers studying incretin biology. As a dual agonist, it engages both the GIP and GLP-1 receptors, providing a model for examining how combined incretin signaling differs from selective GLP-1 activation. Studies use Tirzepatide to investigate receptor-binding dynamics and the synergistic effects of dual engagement on pancreatic and metabolic signaling in cellular models.
Glucose Homeostasis & Insulin Response
In metabolic research, Tirzepatide is investigated for its influence on glucose-dependent insulin secretion. Researchers study how dual incretin signaling modulates the insulinotropic response in pancreatic beta-cell models, examining the interplay between the two receptor pathways in regulating glucose handling.
Adipose Metabolism & Energy Partitioning
Recent studies have utilized Tirzepatide to investigate effects on lipid metabolism. By examining how combined GIP and GLP-1 engagement influences adipose signaling and substrate partitioning, researchers explore the peptide's role in energy-balance and body-composition research within preclinical models.
For research use only.
Trusted by 150+ Customers
60-day money-back guaranteeon every order
